4c2x: Difference between revisions
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4c2x FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4c2x OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4c2x RCSB], [http://www.ebi.ac.uk/pdbsum/4c2x PDBsum]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4c2x FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4c2x OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4c2x RCSB], [http://www.ebi.ac.uk/pdbsum/4c2x PDBsum]</span></td></tr> | ||
</table> | </table> | ||
== Function == | |||
[[http://www.uniprot.org/uniprot/NMT2_HUMAN NMT2_HUMAN]] Adds a myristoyl group to the N-terminal glycine residue of certain cellular and viral proteins. | |||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 21: | Line 23: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Glycylpeptide N-tetradecanoyltransferase]] | [[Category: Glycylpeptide N-tetradecanoyltransferase]] | ||
[[Category: Brannigan, J A | [[Category: Brannigan, J A]] | ||
[[Category: Brassat, U | [[Category: Brassat, U]] | ||
[[Category: Heal, W P | [[Category: Heal, W P]] | ||
[[Category: Mann, D J | [[Category: Mann, D J]] | ||
[[Category: Serwa, R A | [[Category: Serwa, R A]] | ||
[[Category: Tate, E W | [[Category: Tate, E W]] | ||
[[Category: Thinon, E | [[Category: Thinon, E]] | ||
[[Category: Wilkinson, A J | [[Category: Wilkinson, A J]] | ||
[[Category: Wright, M H | [[Category: Wright, M H]] | ||
[[Category: Myristoylation]] | [[Category: Myristoylation]] | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||